Back to Search Start Over

Electrochemical immunosensing of Growth arrest‐specific 6 in human plasma and tumor cell secretomes

Authors :
Pablo García de Frutos
Cristina Muñoz-San Martín
Verónica Serafín
Pilar Navarro
María Pedrero
Rodrigo Barderas
Susana Campuzano
Ana Montero-Calle
Neus Martínez-Bosch
Guillermo Solís-Fernández
Víctor Pérez-Ginés
Maria Gamella
Montserrat Batlle
Rebeca M. Torrente-Rodríguez
José M. Pingarrón
ECSEL Joint Undertaking
Ministerio de Ciencia e Innovación (España)
Comunidad de Madrid (España)
Fundación La Marató TV3
Instituto de Salud Carlos III
Flanders Research Foundation (FWO)
Complutense University of Madrid (España)
European Commission
Ministerio de Ciencia, Innovación y Universidades (España)
Agencia Estatal de Investigación (España)
Comunidad de Madrid
Fundació La Marató de TV3
Ministerio de Educación, Cultura y Deporte (España)
Research Foundation - Flanders
Universidad Complutense de Madrid
Source :
Repisalud, Instituto de Salud Carlos III (ISCIII)
Publication Year :
2021
Publisher :
Wiley, 2021.

Abstract

Growth arrest-specific 6 (GAS6) protein plays a key role in processes related to proliferation, inflammation, angiogenesis, and atherosclerotic plaque formation. In addition, it has been reported that plasma levels of GAS6 are related to cancer prognosis and other relevant pathologies, such as heart failure or sepsis. We report here the first electrochemical immunoplatform for the determination of GAS6, which has demonstrated to be competitive with other available methodologies in terms of cost, simplicity, and decentralized application. The developed immunoplatform involves a sandwich immunoassay using magnetic microparticles (MBs) and uses amperometric detection at disposable screen-printed carbon electrodes (SPCEs). The MBs were modified with an antibody specific to GAS6 for its selective capture, which is further recognized by a biotinylated secondary antibody subsequently labeled with a streptavidin-horseradish peroxidase (Strep-HRP) conjugate. The electrochemical detection was carried out using the hydroquinone (HQ)/H2O2 system. The developed bioplatform exhibits a great selectivity and low limit of detection (27 pg/mL) that allowed the determination of the GAS6 circulating level in plasma samples from patients suffering heart failure (HF) and diagnosed with pancreatic ductal adenocarcinoma (PDAC), as well as the determination of the target protein in raw secretomes of human colorectal cancer cell lines.<br />This work is part of the POSITION-II project fundedby the ECSEL Joint Undertaking under grant numberEcsel-783132-Position-II-2017-IA;www.position-2.eu,and PCI2018-093067 (Spanish Ministerio de Ciencia eInnovación) to M.P. The financial support of PID2019-103899RB-I00 (Spanish Ministerio de Ciencia e Inno-vación) Research Project to S.C., PI17CIII/00045 andPI20CIII/00019 grants from the AES-ISCIII program toR.B. and the TRANSNANOAVANSENS-CM Program fromthe Comunidad de Madrid (Grant S2018/NMT-4349) toS.C., RTI2018-095672-B-I00 (Spanish Ministerio de Cienciae Innovación) to P.G.F.; Fundació la Marató de TV3 project081010toM.B.; researchprojectPI20/00625,fromtheAES-ISCIII/FEDER program, to P.N, are gratefully acknowl-edged. A. Montero-Calle acknowledges the support of theFPU predoctoral contracts by the Spanish Ministerio deEducación, Cultura y Deporte. G.S-F. is recipient of a pre-doctoral contract (grant number 1193818N) supported byThe Flanders Research Foundation (FWO). C. Muñoz-SanMartín acknowledges a predoctoral contract from Complutense University of Madrid. R.M. Torrente-Rodríguezacknowledges a Talento-Contract from Comunidad deMadrid (2019-T2/IND-15965).

Details

ISSN :
26985977
Volume :
2
Database :
OpenAIRE
Journal :
Electrochemical Science Advances
Accession number :
edsair.doi.dedup.....0ff23bcfa8a28814cb247b9ca50b0199
Full Text :
https://doi.org/10.1002/elsa.202100096